Vicinal substituted cyclopropyl compounds which are inhibitors of phosphodiesterase 10 are described as are processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of mammals, including human(s) for central nervous system (CNS) disorders and other disorders which may affect CNS function, for example neurological, neurodegenerative and psychiatric disorders including, but not limited to, those comprising cognitive deficits or schizophrenic symptoms.
本文描述了邻位取代的
环丙基化合物,它们是
磷酸二酯酶10的
抑制剂,以及这些化合物的处理方法、制药组合物、制药制剂和在哺乳动物,包括人类中治疗中枢神经系统(CNS)疾病和其他可能影响CNS功能的疾病的制药用途,例如神经、神经退行性和精神障碍,包括但不限于那些包括认知缺陷或精神分裂症状的疾病。